Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction - PubMed (original) (raw)
Randomized Controlled Trial
Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction
Irene Cantero et al. Nutrients. 2017.
Abstract
The prevalence of non-alcoholic-fatty-liver-disease (NAFLD) is associated with obesity, diabetes, and metabolic syndrome (MS). This study aimed to evaluate the influence of two energy-restricted diets on non-invasive markers and scores of liver damage in obese individuals with features of MS after six months of follow-up and to assess the role of fiber content in metabolic outcomes. Seventy obese individuals from the RESMENA (Reduction of Metabolic Syndrome in Navarra) study were evaluated at baseline and after six months of energy-restricted nutritional intervention (American Heart Association (AHA) and RESMENA dietary groups). Dietary records, anthropometrical data, body composition by dual energy X-ray absorptiometry (DXA), and routine laboratory measurements were analyzed by standardized methods. Regarding liver status, cytokeratin-18 fragments and several non-invasive scores of fatty liver were also assessed. The RESMENA strategy was a good and complementary alternative to AHA for the treatment of obesity-related comorbidities. Participants with higher insoluble fiber consumption (≥7.5 g/day) showed improvements in fatty liver index (FLI), hepatic steatosis index (HIS), and NAFLD liver fat score (NAFLD_LFS), while gamma-glutamyl transferase (GGT) and transaminases evidenced significant improvements as a result of fruit fiber consumption (≥8.8 g/day). Remarkably, a regression model evidenced a relationship between liver status and fiber from fruits. These results support the design of dietary patterns based on the consumption of insoluble fiber and fiber from fruits in the context of energy restriction for the management of obese patients suffering fatty liver disease.
Keywords: AHA; RESMENA; fatty liver disease; fiber; insoluble fiber; metabolic syndrome; obesity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Figure 1
Study design flowchart. AHA: American Heart Association; IDF: International Diabetes Federation; MS: metabolic syndrome.
Figure 2
Regression analysis with changes in FLI and fruit fiber.
References
- Kobayashi Y., Tatsumi H., Hattori M., Sugiyama H., Wada S., Kuwahata M., Tanaka S., Kanemasa K., Sumida Y., Naito Y., et al. Comparisons of dietary intake in japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus. J. Clin. Biochem. Nutr. 2016;59:215–219. doi: 10.3164/jcbn.16-7. - DOI - PMC - PubMed
- Katsagoni C.N., Georgoulis M., Papatheodoridis G.V., Panagiotakos D.B., Kontogianni M.D. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. Metabolism. 2017;68:119–132. doi: 10.1016/j.metabol.2016.12.006. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous